Page last updated: 2024-12-11

angiotensin amide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Angiotensin Amide: The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

psilostachyin A: has antineoplastic, anti-inflammatory, leishmanicidal, and molluscicidal activities; isolated from Ambrosia psilostachya; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10351092
CHEMBL ID409803
CHEBI ID135950
SCHEMBL ID9324
MeSH IDM0001200
PubMed CID5320767
CHEMBL ID270060
MeSH IDM0001200

Synonyms (64)

Synonym
1-aspartic acid-beta-amide 5-valine-angiotensin ii
angiotensin (ciba) (van)
n-(1-(n-(n-(n-(n-(n(sup 2)-l-asparaginyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-3-phenyl-l-alanine
rainbow trout angiotensin ii
5-valine-angiotensin ii aspartic-beta-amide
(1-asparagine-5-valine)-angiotensin ii
angiotensinamide
nsc 107678
angiotensinamidum [inn-latin]
angiotensin ii aspartic-beta-amide, 5-l-valine
l-asparaginyl-l-arginyl-l-valyl-l-tyrosyl-l-valyl-l-histidyl-l-prolyl-l-phenylalanin
angio tensinamida [inn-spanish]
5-valine-angiotensin ii-beta-amide
ipertensina
einecs 200-182-3
l-phenylalanine, n-(1-(n-(n-(n-(n-(n2-l-asparaginyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-
1-l-asparagine-5-l-valineangiotensin ii
angiotensin ii amide, 5-l-valine-
val-5-angiotensin ii amide
nsc-107678
5-valyl-angiotensin ii amide
1-asparaginyl-5-valyl-angiotensin ii
hypertensine
1-asparatic acid-5-valine-angiotensin ii amide
angiotensin amide
angiotensin ii, 1-l-asparagine-5-l-valine-
hypertensinamide
angiotensin ii amide 5-valine
5-valine angiotensin ii amide
5-valine-angiotensin amide ii
angiotensin amide, 5-l-valine-
1-asparagine-5-valine-angiotensin ii
angiotensin ii-amide
angiotensin ii-5-valine amide
5-l-valine-angiotensin ii amide
53-73-6
CHEBI:135950
CHEMBL409803
asn-arg-val-tyr-val-his-pro-phe
angio tensinamida
angiotensinamide [inn]
angiotensin amide [usan:nf]
7wal1x78kv ,
unii-7wal1x78kv
angiotensinamidum
SCHEMBL9324
mfcd00167643
[asn1, val5]-angiotensin ii, >=97% (hplc)
angiotensine
(asn1,val5)-angiotensin ii (h-asn-arg-val-tyr-val-his-pro-phe-oh)
Q4763296
DB13517
bdbm50228199
DTXSID401018923
(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-2,4-diamino-4-oxobutanoyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1h-imidazol-5-yl)propano
l-asparaginyl-l-arginyl-l-valyl-l-tyrosyl-l-valyl-l-histidyl-l-prolyl-l-phenylalanine
CS-0113476
HY-P2212
3533-47-9
psilostachyin a
CHEMBL270060 ,
bdbm50234866
(3as,6s,7r,8s,8ar)-8-hydroxy-6,8-dimethyl-3-methylidenespiro[4,5,6,8a-tetrahydro-3ah-cyclohepta[b]furan-7,5'-oxolane]-2,2'-dione
DTXSID201316997

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Inhibition of COX-2 has been associated with the therapeutic effects of NSAIDs, whereas inhibition of COX-1 is believed to be the cause of the adverse gastrointestinal effects associated with NSAID therapy."( A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Arellano, FM; Lejkowith, J; Reynolds, MW; Whelton, A; Zhao, SZ, 2001
)
0.31
"This study sought to compare renal safety signals between the COX-2-specific inhibitors rofecoxib and celecoxib, based on spontaneous reports of adverse drug reactions (ADRs) in the World Health Organization/Uppsala Monitoring Centre (WHO/UMC) safety database through the end of the second quarter 2000."( A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Arellano, FM; Lejkowith, J; Reynolds, MW; Whelton, A; Zhao, SZ, 2001
)
0.31
" However, the adverse renal impact of rofecoxib was significantly greater than that of celecoxib."( A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Arellano, FM; Lejkowith, J; Reynolds, MW; Whelton, A; Zhao, SZ, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" In the presence of PBZ or phentolamine blockade, the dose-response curves of oxytocin and VP were shifted to the left, resulting in an apparent doubling of the pressor potency of the neurohypophysial peptides."( The site and the mechanism of phenoxy-benzamine potentiation of the pressor response to oxytocin and vasopressin: in vivo and isolated aortic strips studies.
Chan, WY; Erker, EF, 1977
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)Ki0.00550.00020.10251.7000AID39347
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)Ki0.00550.00020.05211.1000AID39347
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)Ki0.00550.00010.01470.0316AID39347
Transcriptional activator MybGallus gallus (chicken)IC50 (µMol)40.00170.62522.76989.5499AID746038
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)4.60000.00010.995010.0000AID403340
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (62)

Processvia Protein(s)Taxonomy
regulation of gene expressionTranscriptional activator MybGallus gallus (chicken)
mitotic cell cycleTranscriptional activator MybGallus gallus (chicken)
positive regulation of transcription by RNA polymerase IITranscriptional activator MybGallus gallus (chicken)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
protein bindingTranscriptional activator MybGallus gallus (chicken)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional activator MybGallus gallus (chicken)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional activator MybGallus gallus (chicken)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
nucleoplasmTranscriptional activator MybGallus gallus (chicken)
nucleusTranscriptional activator MybGallus gallus (chicken)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID39347Tested for inhibition of radioligand [Sar1,Ile5,8]AII binding to angiotensin II receptor in rat uterus1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
AID168829Compound was tested for pressor response in rat1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II.
AID39346Tested for inhibition of radioligand [Sar1,Ile5,8]AII binding to angiotensin II receptor in rat brain1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
AID1146282Relative binding affinity of the compound assessed as ratio of [Asp1,Ile5]angiotensin II ED50 to compound ED50 for angiotensin 2 receptor in rabbit aortic strips1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Biologically active derivatives of angiotensin for labeling cellular receptors.
AID1130642Induction of pressor activity in nephrectomized, pentolinium-treated rat model relative to angiotensin 21979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity.
AID168828Compound was tested for oxytocic response in rat1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II.
AID169234In vivo residual angiotensin II like activity in rat blood pressure assay1989Journal of medicinal chemistry, Feb, Volume: 32, Issue:2
Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.
AID168240Agonistic activity in rat uterine preparations1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
AID531412Selectivity index, ratio of CC50 for mouse T cells to IC50 for Trypanosoma cruzi trypomastigotes2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID746038Inhibition of c-Myb-induced mim-1 gene expression in doxycyclin-treated chicken HD11 cells after 24 hrs by GFP assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID531411Cytotoxicity against BALB/c mouse T cell after 24 hrs by trypan blue exclusion method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID746037Cytotoxicity against chicken HD11 cells assessed as cell viability after 24 hrs by MTS assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID531415Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes infected in C3H/HeN mouse assessed survival rate at 1 mg/kg/day, ip treated from day 5 to 10 postinfection measured on 100th day postinfection2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID531410Antileishmanial activity against Leishmania mexicana MNYC/BZ/62/M promastigotes after 120 hrs by [3H]thymidine uptake assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID612625Antiinflammatory activity in mouse neutrophils assessed as inhibition of LPS-stimulated TNFalpha cytokine expression at 1 ug/ml after 3 hrs by flow cytometeric analysis2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Psilostachyin, acetylated pseudoguaianolides and their analogues: preparation and evaluation of their anti-inflammatory potential.
AID531413Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes infected in C3H/HeN mouse assessed as reduction in parasitemia at 1 mg/kg/day, ip treated from day 5 to 10 postinfection measured during acute phase of infection relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID320961Inhibition of serotonin release in bovine platelets2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Neural networks as valuable tools to differentiate between sesquiterpene lactones' inhibitory activity on serotonin release and on NF-kappaB.
AID531408Antitrypanosomal activity against Trypanosoma cruzi epimastigotes after 72 hrs by [3H]thymidine uptake assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID531414Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes infected in C3H/HeN mouse assessed as decrease in parasitemia at 1 mg/kg/day, ip treated from day 5 to 10 postinfection measured on day 162008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
AID531409Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes after 24 hrs by [3H]thymidine uptake assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (361)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990308 (85.32)18.7374
1990's9 (2.49)18.2507
2000's16 (4.43)29.6817
2010's23 (6.37)24.3611
2020's5 (1.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.00 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.81%)5.53%
Trials0 (0.00%)5.53%
Reviews8 (2.17%)6.00%
Reviews0 (0.00%)6.00%
Case Studies5 (1.36%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other353 (95.66%)84.16%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]